ORCHARD THERAPEUTICS PLC's ticker is ORTX and the CUSIP is 68570P101. A total of 80 filers reported holding ORCHARD THERAPEUTICS PLC in Q3 2021. The put-call ratio across all filers is 4.06 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $3,194,820 | -25.8% | 8,611,375 | 0.0% | 0.00% | – |
Q3 2022 | $4,306,000 | -14.4% | 8,611,375 | 0.0% | 0.00% | -100.0% |
Q2 2022 | $5,031,000 | -17.9% | 8,611,375 | 0.0% | 0.00% | – |
Q1 2022 | $6,131,000 | -46.1% | 8,611,375 | 0.0% | 0.00% | -100.0% |
Q4 2021 | $11,367,000 | -42.6% | 8,611,375 | 0.0% | 0.00% | -50.0% |
Q3 2021 | $19,806,000 | -47.6% | 8,611,375 | 0.0% | 0.00% | -33.3% |
Q2 2021 | $37,804,000 | -39.5% | 8,611,375 | 0.0% | 0.00% | -40.0% |
Q1 2021 | $62,519,000 | +18.2% | 8,611,375 | -29.7% | 0.01% | 0.0% |
Q4 2020 | $52,897,000 | +5.1% | 12,244,590 | 0.0% | 0.01% | 0.0% |
Q3 2020 | $50,325,000 | -31.5% | 12,244,590 | 0.0% | 0.01% | -37.5% |
Q2 2020 | $73,468,000 | -20.3% | 12,244,590 | 0.0% | 0.01% | -38.5% |
Q1 2020 | $92,202,000 | -45.4% | 12,244,590 | -0.2% | 0.01% | -31.6% |
Q4 2019 | $168,755,000 | -30.4% | 12,273,064 | -39.9% | 0.02% | -34.5% |
Q3 2019 | $242,443,000 | -15.1% | 20,407,650 | 0.0% | 0.03% | -12.1% |
Q2 2019 | $285,503,000 | -21.8% | 20,407,650 | 0.0% | 0.03% | -25.0% |
Q1 2019 | $364,889,000 | +13.7% | 20,407,650 | 0.0% | 0.04% | 0.0% |
Q4 2018 | $321,012,000 | – | 20,407,650 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |